Furthermore, PARP inhibition counteracted diabetes-induced systemic oxidative stress and 4-hydroxynonenal adduct accumulation in peripheral nerves and improved nerve fiber function [27]. This evidence concerns the gene PARP1 and diabetes mellitus.